These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
391 related articles for article (PubMed ID: 22863801)
1. Screening for latent tuberculosis in anti-TNF-α candidate patients in a high tuberculosis incidence setting. Saidenberg-Kermanac'h N; Semerano L; Naccache JM; Brauner M; Falgarone G; Dumont-Fischer D; Guillot X; Valeyre D; Boissier MC Int J Tuberc Lung Dis; 2012 Oct; 16(10):1307-14. PubMed ID: 22863801 [TBL] [Abstract][Full Text] [Related]
2. Comparison of an interferon-gamma assay with tuberculin skin testing for detection of tuberculosis (TB) infection in patients with rheumatoid arthritis in a TB-endemic population. Ponce de Leon D; Acevedo-Vasquez E; Alvizuri S; Gutierrez C; Cucho M; Alfaro J; Perich R; Sanchez-Torres A; Pastor C; Sanchez-Schwartz C; Medina M; Gamboa R; Ugarte M J Rheumatol; 2008 May; 35(5):776-81. PubMed ID: 18398944 [TBL] [Abstract][Full Text] [Related]
3. [The clinical application of quantiferon TB-2G: its usefulness and limitations]. Sato S; Nagai H Kekkaku; 2011 Feb; 86(2):101-12. PubMed ID: 21404654 [TBL] [Abstract][Full Text] [Related]
4. Diagnosis of latent tuberculosis infection before initiation of anti-tumor necrosis factor therapy using both tuberculin skin test and QuantiFERON-TB Gold In Tube assay. Kim HC; Jo KW; Jung YJ; Yoo B; Lee CK; Kim YG; Yang SK; Byeon JS; Kim KJ; Ye BD; Shim TS Scand J Infect Dis; 2014 Nov; 46(11):763-9. PubMed ID: 25195652 [TBL] [Abstract][Full Text] [Related]
5. QuantiFERON-TB Gold and the TST are both useful for latent tuberculosis infection screening in autoimmune diseases. Bartalesi F; Vicidomini S; Goletti D; Fiorelli C; Fiori G; Melchiorre D; Tortoli E; Mantella A; Benucci M; Girardi E; Cerinic MM; Bartoloni A Eur Respir J; 2009 Mar; 33(3):586-93. PubMed ID: 19047313 [TBL] [Abstract][Full Text] [Related]
6. Influence of replacing tuberculin skin test with ex vivo interferon γ release assays on decision to administer prophylactic antituberculosis antibiotics before anti-TNF therapy. Mariette X; Baron G; Tubach F; Lioté F; Combe B; Miceli-Richard C; Flipo RM; Goupille P; Allez M; Salmon D; Emilie D; Carcelain G; Ravaud P Ann Rheum Dis; 2012 Nov; 71(11):1783-90. PubMed ID: 22258485 [TBL] [Abstract][Full Text] [Related]
7. Dual latent tuberculosis screening with tuberculin skin tests and QuantiFERON-TB assays before TNF-α inhibitor initiation in children in Spain. Calzada-Hernández J; Anton J; Martín de Carpi J; López-Montesinos B; Calvo I; Donat E; Núñez E; Blasco Alonso J; Mellado MJ; Baquero-Artigao F; Leis R; Vegas-Álvarez AM; Medrano San Ildefonso M; Pinedo-Gago MDC; Eizaguirre FJ; Tagarro A; Camacho-Lovillo M; Pérez-Gorricho B; Gavilán-Martín C; Guillén S; Sevilla-Pérez B; Peña-Quintana L; Mesa-Del-Castillo P; Fortuny C; Tebruegge M; Noguera-Julian A Eur J Pediatr; 2023 Jan; 182(1):307-317. PubMed ID: 36335186 [TBL] [Abstract][Full Text] [Related]
8. Evaluation of the usefulness of interferon-gamma release assays and the tuberculin skin test for the detection of latent Mycobacterium tuberculosis infections in Korean rheumatic patients who are candidates for biologic agents. Kim JH; Won S; Choi CB; Sung YK; Song GG; Bae SC Int J Rheum Dis; 2015 Mar; 18(3):315-22. PubMed ID: 25351815 [TBL] [Abstract][Full Text] [Related]
9. QuantiFERON-TB Gold In-Tube test (QFT-GIT) for the screening of latent tuberculosis in recent immigrants to Italy. Saracino A; Scotto G; Fornabaio C; Martinelli D; Faleo G; Cibelli D; Tartaglia A; Di Tullio R; Fazio V; Prato R; Monno L; Angarano G New Microbiol; 2009 Oct; 32(4):369-76. PubMed ID: 20128443 [TBL] [Abstract][Full Text] [Related]
10. Comparison of QuantiFERON-TB Gold with tuberculin skin test for detection of latent tuberculosis infection before kidney transplantation. Kim JS; Cho JH; Park GY; Kang YJ; Kwon O; Choi JY; Park SH; Kim YL; Kim HK; Huh S; Kim CD Transplant Proc; 2013 Oct; 45(8):2899-902. PubMed ID: 24157000 [TBL] [Abstract][Full Text] [Related]
11. Comparison of latent tuberculosis infection screening strategies before tumor necrosis factor inhibitor treatment in inflammatory arthritis: IGRA-alone versus combination of TST and IGRA. Jeong DH; Kang J; Jung YJ; Yoo B; Lee CK; Kim YG; Hong S; Shim TS; Jo KW PLoS One; 2018; 13(7):e0198756. PubMed ID: 29975703 [TBL] [Abstract][Full Text] [Related]
12. Combined use of a TST and the T-SPOT®.TB assay for latent tuberculosis infection diagnosis before anti-TNF-α treatment. Jung YJ; Lyu J; Yoo B; Lee CK; Kim YG; Yang SK; Byeon JS; Kim KJ; Ye BD; Lee KH; Lee SD; Kim WS; Kim DS; Shim TS Int J Tuberc Lung Dis; 2012 Oct; 16(10):1300-6. PubMed ID: 22863375 [TBL] [Abstract][Full Text] [Related]
13. Clinical applicability of Quantiferon-TB-Gold testing in psoriasis patients during long-term anti-TNF-alpha treatment: a prospective, observational study. Garcovich S; Ruggeri A; D'Agostino M; Ardito F; De Simone C; Delogu G; Fadda G J Eur Acad Dermatol Venereol; 2012 Dec; 26(12):1572-6. PubMed ID: 21923840 [TBL] [Abstract][Full Text] [Related]
14. Comparison of the QuantiFERON-TB Gold In-Tube test with the tuberculin skin test for detecting latent tuberculosis infection in hemodialysis patients. Seyhan EC; Sökücü S; Altin S; Günlüoğlu G; Trablus S; Yilmaz D; Koksalan OK; Issever H Transpl Infect Dis; 2010 Apr; 12(2):98-105. PubMed ID: 19903322 [TBL] [Abstract][Full Text] [Related]
15. Screening for latent tuberculosis infection: performance of tuberculin skin test and interferon-γ release assays under real-life conditions. Kleinert S; Tony HP; Krueger K; Detert J; Mielke F; Rockwitz K; Schwenke R; Burmester GR; Diel R; Feuchtenberger M; Kneitz C Ann Rheum Dis; 2012 Nov; 71(11):1791-5. PubMed ID: 22586160 [TBL] [Abstract][Full Text] [Related]
16. QuantiFERON-TB Gold In-Tube assay for screening arthritis patients for latent tuberculosis infection before starting anti-tumor necrosis factor treatment. Lee H; Park HY; Jeon K; Jeong BH; Hwang JW; Lee J; Cha HS; Koh EM; Kang ES; Koh WJ PLoS One; 2015; 10(3):e0119260. PubMed ID: 25746854 [TBL] [Abstract][Full Text] [Related]
17. Use of Quantiferon-TB-Gold in Tube(®) test for detecting latent tuberculosis in patients considered as candidates for anti-TNF therapy in routine clinical practice. García-Gasalla M; Fernández-Baca V; Juan-Mas A; Payeras-Cifre A; Cifuentes-Luna C; Taberner-Ferrer R; Riera-Oliver J; Ros-Villamajó I; Navarro-Fernández V; Morey Torrandell C; Gallegos-Alvarez C; Mir-Villadrich I Enferm Infecc Microbiol Clin; 2013 Feb; 31(2):76-81. PubMed ID: 22902246 [TBL] [Abstract][Full Text] [Related]
18. Preventing tuberculosis flare in patients with inflammatory rheumatic diseases receiving tumor necrosis factor-alpha inhibitors in India -- An audit report. Malaviya AN; Kapoor S; Garg S; Rawat R; Shankar S; Nagpal S; Khanna D; Furst DE J Rheumatol; 2009 Jul; 36(7):1414-20. PubMed ID: 19487263 [TBL] [Abstract][Full Text] [Related]
19. Diagnosis of tuberculosis infection by tuberculin skin test and a whole-blood interferon-γ release assay in patients considered for anti-tumor necrosis factor-α therapy. Casas S; Andreu A; Juanola X; Bordas X; Alcaide F; Moure R; Anibarro L; Cuchí E; Esteve M; Ortiz V; Guerra MR; Rodríguez J; Reina D; Salvador G; Guardiola J; Surís X; Pascual MA; Martí C; Martínez-Lacasa X; Cuquet J; Gonzalez L; Santin M Diagn Microbiol Infect Dis; 2011 Sep; 71(1):57-65. PubMed ID: 21851871 [TBL] [Abstract][Full Text] [Related]
20. Clinical experience of QuantiFERON(®) -TB Gold testing in patients with psoriasis treated with tumour necrosis factor blockers in Taiwan. Chiu HY; Hsueh PR; Tsai TF Br J Dermatol; 2011 Mar; 164(3):553-9. PubMed ID: 21083541 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]